Some of these RBPs are involved in this anti-apoptotic effect by regulating apoptosis-related mRNAs in breast cancer target cells, such as Myc, Mcl-1, p53, Bcl-2 and other mRNAs (108, 109). This evidence concerns the gene BCL2 and breast carcinoma.